M Mammen

427 total citations
12 papers, 356 citations indexed

About

M Mammen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, M Mammen has authored 12 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Physiology. Recurrent topics in M Mammen's work include Pain Mechanisms and Treatments (2 papers), Receptor Mechanisms and Signaling (2 papers) and Respiratory Support and Mechanisms (2 papers). M Mammen is often cited by papers focused on Pain Mechanisms and Treatments (2 papers), Receptor Mechanisms and Signaling (2 papers) and Respiratory Support and Mechanisms (2 papers). M Mammen collaborates with scholars based in United States, India and Germany. M Mammen's co-authors include George M. Whitesides, Georg Dahmann, Sharath S. Hegde, Tod Steinfeld, Bret M. Benton, Dmitri Debabov, Christopher S. Lunde, Martin Wj, K.C. Kwan and James W. Janc and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Antimicrobial Agents and Acta Radiologica.

In The Last Decade

M Mammen

11 papers receiving 353 citations

Peers

M Mammen

MB

OC

EPIDE

RNMI

BIOMA

Ilona Papp Germany

Meike Roskamp Germany

Silvia Angeloni Switzerland

Florian Manzenrieder Germany

Marlena Stadtmüller Germany

Noriko Nagahori Japan

Stefania Ordanini Italy

Philipp René Spycher Switzerland

Michael A. Gelman United States

Ilona Papp Germany

M Mammen

306 ×1.5

MB

190 ×1.5

OC

72 ×0.8

EPIDE

65 ×1.0

RNMI

84 ×2.5

BIOMA

Citations per year, relative to M Mammen M Mammen (= 1×) peers Ilona Papp

Countries citing papers authored by M Mammen

Since Specialization

Citations

This map shows the geographic impact of M Mammen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mammen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mammen more than expected).

Fields of papers citing papers by M Mammen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mammen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mammen. The network helps show where M Mammen may publish in the future.

Co-authorship network of co-authors of M Mammen

This figure shows the co-authorship network connecting the top 25 collaborators of M Mammen. A scholar is included among the top collaborators of M Mammen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mammen. M Mammen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Mammen, M, et al.. (2025). Evaluation of Different Generative Models to Support the Validation of Advanced Driver Assistance Systems. Applied Mechanics. 6(2). 39–39.

2.

Mammen, M, et al.. (2017). Comparison of enhancement of analgesic effect of intrathecal neostigmine by intrathecal clonidine and transdermal nitroglycerin patch on bupivacaine spinal anesthesia. Anesthesia Essays and Researches. 11(4). 993–993. 6 indexed citations

3.

Steinfeld, Tod, et al.. (2009). In Vitro Characterization of TD-4208, a Lung-Selective and Long-Acting Muscarinic Antagonist Bronchodilator.. A4553–A4553. 11 indexed citations

4.

McNamara, Alexander, et al.. (2009). TD-5959: A Novel Bifunctional Muscarinic Antagonist – β ₂ -Adrenergic Agonist with Potent and Sustained In Vivo Bronchodilator Activity in Guinea Pigs.. A6195–A6195. 2 indexed citations

5.

Aiyar, Jayashree, et al.. (2009). In Vitro Characterization of TD-5959: A Novel Bifunctional Molecule with Muscarinic Antagonist and β ₂ -Adrenergic Agonist Activity.. A4552–A4552. 6 indexed citations

6.

McNamara, Alexander, K.C. Kwan, Martin Wj, et al.. (2009). Comparative Preclinical Efficacy of Combivent and a Novel, Bifunctional Muscarinic Antagonist and β2-Adrenergic Agonist.. A4573–A4573. 1 indexed citations

7.

Aiyar, Jayashree, et al.. (2009). Crosstalk between Heterologously Expressed M 3 -Muscarinic Receptors and β 2 Adrenoceptors.. 1 indexed citations

8.

McNamara, Alexander, K.C. Kwan, Martin Wj, et al.. (2009). TD-4208: A Novel, Lung-Selective Muscarinic Antagonist with Sustained Bronchoprotective Activity in Preclinical Models.. A4557–A4557. 1 indexed citations

9.

Benton, Bret M., Eefjan Breukink, Dmitri Debabov, et al.. (2007). O258 Telavancin inhibits peptidoglycan biosynthesis through preferential targeting of transglycosylation: evidence for a multivalent interaction between telavancin and lipid II. International Journal of Antimicrobial Agents. 29. S51–S52. 10 indexed citations

10.

Mammen, M, Georg Dahmann, & George M. Whitesides. (1995). Effective Inhibitors of Hemagglutination by Influenza Virus Synthesized from Polymers Having Active Ester Groups. Insight into Mechanism of Inhibition. Journal of Medicinal Chemistry. 38(21). 4179–4190. 312 indexed citations

11.

Zhu, Zhenping, T. Ghose, David W. Hoskin, et al.. (1994). Radioimmunotherapy of human B-cell chronic lymphocytic leukemia in nude mice.. PubMed. 54(19). 5111–7. 5 indexed citations

12.

Heyman, Samuel N. & M Mammen. (1991). Effect of Indomethacin and Salt Depletion on Renal Proton MR Imaging. Acta Radiologica. 32(6). 524–526. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact